GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma

Summary

GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma is a clinical trial^[1].

Key Facts

• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma is in the country of Belgium^[2].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma is in the country of France^[3].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's instance of is recorded as clinical trial^[4].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's start time is recorded as +2012-09-30T00:00:00Z^[5].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's end time is recorded as +2016-08-31T00:00:00Z^[6].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's main subject is recorded as lymphoma^[7].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's number of participants is recorded as {'unit': '1', 'amount': '+671'}^[8].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's title is recorded as Randomized Phase III Study Using a Pet-driven Strategy and Comparing GA101 OR Rituximab Associated to a Chemotherapy Delivered Every 14 Days (ACVBP or CHOP) in DLBCL CD20+ Lymphoma Untreated Patients From 18 to 60 Presenting With 1 or More Adverse Prognostic Factors of the Age-adjusted IPI^[9].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's short name is recorded as GAINED^[10].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's ClinicalTrials.gov ID is recorded as NCT01659099^[12].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}^[13].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's research intervention is recorded as (RS)-cyclophosphamide^[14].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's research intervention is recorded as rituximab^[15].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's research intervention is recorded as doxorubicin^[16].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's research intervention is recorded as prednisone^[17].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's clinical trial phase is recorded as phase III clinical trial^[18].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's research site is recorded as Brugmann University Hospital^[19].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's research site is recorded as Ghent University Hospital^[20].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's research site is recorded as Curie Institute^[21].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's research site is recorded as Centre Henri-Becquerel^[22].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's research site is recorded as Institut Gustave Roussy^[23].
• GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma's study type is recorded as interventional study^[24].